LifeVantage (NASDAQ:LFVN - Get Free Report) will likely be posting its quarterly earnings results after the market closes on Wednesday, February 5th. Analysts expect LifeVantage to post earnings of $0.14 per share and revenue of $67.41 million for the quarter. Individual interested in registering for the company's earnings conference call can do so using this link.
LifeVantage (NASDAQ:LFVN - Get Free Report) last released its earnings results on Tuesday, October 29th. The company reported $0.15 earnings per share for the quarter, hitting analysts' consensus estimates of $0.15. LifeVantage had a net margin of 2.11% and a return on equity of 29.24%. The firm had revenue of $47.21 million for the quarter.
LifeVantage Price Performance
NASDAQ LFVN traded down $1.24 during trading hours on Friday, reaching $21.16. 200,173 shares of the company's stock traded hands, compared to its average volume of 232,293. The firm has a market cap of $264.92 million, a PE ratio of 66.13 and a beta of 0.82. LifeVantage has a 52-week low of $5.22 and a 52-week high of $27.38. The firm has a 50-day simple moving average of $18.62 and a 200 day simple moving average of $13.32.
Analyst Ratings Changes
Several analysts recently weighed in on LFVN shares. Lake Street Capital assumed coverage on LifeVantage in a research note on Thursday, December 19th. They issued a "buy" rating and a $26.00 price target on the stock. Craig Hallum began coverage on LifeVantage in a research note on Tuesday, January 14th. They issued a "buy" rating and a $35.00 target price on the stock.
Get Our Latest Analysis on LifeVantage
About LifeVantage
(
Get Free Report)
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Featured Stories

Before you consider LifeVantage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeVantage wasn't on the list.
While LifeVantage currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.